Things We Do for No Reason™: Routine pretreatment with a P2Y12 receptor inhibitor before invasive coronary angiography for patients with a non-ST elevation acute coronary syndrome

J Hosp Med. 2023 Feb;18(2):177-180. doi: 10.1002/jhm.12931. Epub 2022 Aug 3.

Authors

Kevin O'Malley¹, Yoseob Joseph Hwang^{1

2}, Jeffrey Trost¹, Leonard Feldman^{1

3}

Affiliations

¹ Department of Medicine, Division of Hospital Medicine at Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
² Center for Drug Safety and Effectiveness, Johns Hopkins University, Baltimore, Maryland, USA.
³ Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

PMID: 35920593
DOI: 10.1002/jhm.12931

No abstract available

MeSH terms

Acute Coronary Syndrome* / diagnostic imaging
Acute Coronary Syndrome* / drug therapy
Coronary Angiography
Humans
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists / therapeutic use
Treatment Outcome

Substances

Purinergic P2Y Receptor Antagonists
Platelet Aggregation Inhibitors